Here are four insights:
1. Richard Laherty, MBBS, of Queensland Neurosurgery and Spine Surgery, performed the first two anterior lumbar interbody fusions with the Endoskeleton technology at Princess Alexandra Hospital in Brisbane.
2. The company’s line of Endoskeleton titanium implants includes proprietary surface technology at the macro, micro and cellular levels.
3. The technology’s surface topographies encourage the “upregulation of osteogenic and angiogenic factors necessary for bone growth, encouraging natural production of bone morphogenetic proteins, downregulating inflammatory factors and creating the potential for a faster and more robust fusion.”
4. Titan Spine earned Australian Therapeutic Goods Administration approval in 2014.
More articles on devices:
5 opportunities, forecasts in global orthopedic implants market
OrthoPediatrics amends distribution agreement with Bioretec: 5 things to know
8 orthopedic, spine device companies who spent the most on non-research payments to Florida physicians – Zimmer Biomet leads with $4.473M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
